Related Experiment Video
Updated: Jun 26, 2025

07:39
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
73
Calreticulin regulates the expression of MMP14 and ADAR1 through EIF2AK2 signaling to promote the proliferation and
Li Liang1, Jin Wang1, Tao Guo1
1Department of Laser, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Neoplasma
|May 20, 2024
Summary
Calreticulin (CALR) and EIF2AK2 promote melanoma progression. Targeting both CALR and EIF2AK2 may offer an effective anti-tumor strategy, potentially via MMP14 and ADAR1 signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Calreticulin (CALR) is implicated in tumor development.
- Abnormal CALR expression is observed in various cancers.
Purpose of the Study:
- To investigate the roles of CALR and EIF2AK2 in melanoma.
- To explore the underlying molecular mechanisms of CALR and EIF2AK2 in melanoma progression.
Main Methods:
- Analyzed CALR and EIF2AK2 expression in melanoma tissues.
- Utilized cell models with CALR and EIF2AK2 knockdown/overexpression.
- Performed migration, invasion, apoptosis, proliferation, and ROS assays.
- Detected protein levels of CALR, EIF2AK2, ADAR1, and MMP14 via Western blotting.
Main Results:
- CALR and EIF2AK2 were upregulated in melanoma tissues.
- CALR overexpression increased EIF2AK2, MMP14, and ADAR1 expression.
- CALR knockdown decreased EIF2AK2, MMP14, and ADAR1 expression.
- EIF2AK2 knockdown reversed CALR-induced MMP14 and ADAR1 upregulation.
Conclusions:
- CALR and EIF2AK2 promote melanoma progression.
- Combined knockdown of CALR and EIF2AK2 inhibits melanoma progression.
- Potential therapeutic targeting of CALR and EIF2AK2 via MMP14/ADAR1 signaling.
Related Concept Videos
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

